External Contributer Articles of Labiotech.eu

About

Many authors are contributing to Labiotech.eu. If you want to join them, feel free to reach out to us with your article ideas.

Articles by External Contributor

Expert Advice 5 Jul 2021

Why the Right Team is Key for Biotech Success

For any startup, and especially for biotechnology startups, success depends on three main factors: science, financing, and people. One of the key factors investors look for is having a management team that can raise money and make good use of it to advance the science of the company. According to Sinclair Dunlop, Managing Partner at […]

July 5, 2021 - 7 minutesmins - By External Contributor

Opinion 21 Jun 2021

A Window to the Past: Is the Biotech Investment Boom Going to Last?

The biotech industry has been going through a period of fast growth in recent years. To uncover whether the current biotech investment boom will last, let’s look at what history can teach us. A window is something that opens and shuts. So the clear implication of everyone talking about a ‘public market window’ in the […]

June 21, 2021 - 7 minutesmins - By External Contributor

Opinion 26 Apr 2021

How Good Investor Communications Determine Success in a Covid World

During the pandemic, the biotech industry has continued to complete deals, even without face-to-face interactions. Startups should leverage communication to sustain their investor relations and build strong momentum for late-stage funding rounds in the coming years. Speaking last July, the UK’s Secretary of State for Health and Social Care, Matt Hancock, said the Covid-19 pandemic […]

April 26, 2021 - 6 minutesmins - By External Contributor

peanut allergy treatment DBV Technologies Aimmune Viaskin Palforzia

News and Trends 14 Apr 2021

DBV Battles Aimmune for Share of Peanut Allergy Treatment Market

Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its rival Aimmune. After recent talks with the FDA and EMA, DBV has laid out a comeback plan that could carve it a niche in the peanut allergy treatment market. The French biotech firm DBV is coming back from a snub by […]

April 14, 2021 - 5 minutesmins - By External Contributor

How is Bioprocessing 4.0 Revolutionizing Biomanufacturing?

The digital transformation of biopharmaceutical process development is known as Bioprocessing 4.0. Using the internet of things, digital biomanufacturing creates a network of data sources, materials, equipment, and industry representatives. This creates a competitive advantage, increases productivity, and boosts the value of biomanufacturing. We have spoken to Merrilee Whitney, Head of the BioContinuum™ platform at Merck* […]

March 2, 2021 - 6 minutesmins - By External Contributor

Interview 22 Feb 2021

How Automation Can Augment Drug Discovery Research

Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses the benefits and challenges of introducing automation in drug discovery efforts. The Oxford-based startup Arctoris was established in 2016 with the objective of offering remote access to automated drug discovery. At a time when researchers […]

February 22, 2021 - 8 minutesmins - By External Contributor

Expert Advice 14 Oct 2020

Everything You Need to Know About Biotech Business Models

What’s my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly face. The business model of a biotech company can determine its long-term trajectory to success. In this article, we’ll focus on a typical ‘platform’ biotech company in the biopharma sector whose […]

October 14, 2020 - 6 minutesmins - By External Contributor

In Depth 5 Oct 2020

The Complications Around Patenting Biotechnology

Many people around the world start their mornings with a glass of orange juice. What these vitamin C drinkers might not know is that their ability to enjoy this tangy beverage stems from a victory within a complicated field of intellectual property law: biotechnology patents. Back in 1873, microbiologist Louis Pasteur patented a new yeast-making […]

October 5, 2020 - 7 minutesmins - By External Contributor

News and Trends 14 Sep 2020

The Funding Flow Between European and US Life Sciences

Funding is the lifeline of innovative ventures. In an increasingly uncertain environment, looking at the records of past investments can be essential for making sense of the future and getting closer to discovering what’s next for the life sciences industry. Exploring the differences between the two major groups of life sciences investors and the funding […]

September 14, 2020 - 11 minutesmins - By External Contributor

Expert Advice 26 Aug 2020

Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur

There is usually a big disparity between investors and entrepreneurs regarding the valuation of an early-stage biotech company. How can both sides navigate this negotiation and reach a fair agreement? Many entrepreneurs in biotech might be puzzled when they get a low pre-money valuation for a product with high potential. Even when a product in […]

August 26, 2020 - 7 minutesmins - By External Contributor

Best in Biotech 3 Aug 2020

Meet 10 European Biotech Initiatives Increasing Wildlife Biodiversity

In the fight against shrinking biodiversity, biotechnology could be a lifesaver. These European biotech initiatives are making a difference for wildlife biodiversity worldwide. Human activity is having a massive impact on wildlife biodiversity. According to a global study, 75% of terrestrial ecosystems and 66% of marine ecosystems are severely altered. This threatens the extinction of […]

August 3, 2020 - 6 minutesmins - By External Contributor

News and Trends 16 Jun 2020

UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck

UK biotech startup Bit Bio has received €36.9M in Series A funding to boost the manufacturing efficiency of human cells for use in cell therapy and drug discovery. The impressive deal brings Bit Bio’s total funding to €44.4M since it was spun off from the University of Cambridge in 2016. It’s the second-largest Series A […]

June 16, 2020 - 3 minutesmins - By External Contributor

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

External Contributor

About

Articles by External Contributor

Why the Right Team is Key for Biotech Success

A Window to the Past: Is the Biotech Investment Boom Going to Last?

How Good Investor Communications Determine Success in a Covid World

DBV Battles Aimmune for Share of Peanut Allergy Treatment Market

How is Bioprocessing 4.0 Revolutionizing Biomanufacturing?

How Automation Can Augment Drug Discovery Research

Everything You Need to Know About Biotech Business Models

The Complications Around Patenting Biotechnology

The Funding Flow Between European and US Life Sciences

Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur

Meet 10 European Biotech Initiatives Increasing Wildlife Biodiversity

UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by External Contributor

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!